titlesubmit dateissue date
Now showing items 1-3 of 3
Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations.
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO).
Identification of a cluster of HIV-1 controllers infected with low replicating viruses